Nexentis Technologies Inc.
NXTS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001789192
No open-market purchases or sales by Nexentis Technologies Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $272.3K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Nexentis Technologies Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 15 | 8 | −7 |
| Shares | 1.95M | 40.2K | −1.91M (−97.9%) |
| Value | $448.8K | $149.6K | −$299.3K (−66.7%) |
New holders (2)
Institutions that held Nexentis Technologies Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 4,912 | $18.3K | 0.00% |
| Barclays PLC | 36 | $134 | 0.00% |
Sold out (9)
Institutions that held Nexentis Technologies Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Virtu Financial LLC | 102,417 | $24.0K |
| Geode Capital Management, LLC | 99,441 | $22.9K |
| Renaissance Technologies LLC | 54,310 | $12.5K |
| State Street Corp | 53,700 | $12.4K |
| Citadel Advisors LLC | 46,753 | $10.8K |
| Two Sigma Investments, LP | 35,426 | $8.15K |
| Jane Street Group, LLC | 18,712 | $4.30K |
| Vanguard Group Inc | 16,703 | $3.84K |
| HRT Financial LP | 11,458 | $2.00K |